Broker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higher [Yahoo! Finance]
Silence Therapeutics Plc - American Depository Share (SLN)
Company Research
Source: Yahoo! Finance
The analysts have sharply increased their revenue numbers, with a view that Silence Therapeutics will make substantially more sales than they'd previously expected. Following the latest upgrade, the five analysts covering Silence Therapeutics provided consensus estimates of UK£23m revenue in 2024, which would reflect an uneasy 19% decline on its sales over the past 12 months. Prior to the latest estimates, the analysts were forecasting revenues of UK£21m in 2024. The consensus has definitely become more optimistic, showing a solid increase in revenue forecasts. See our latest analysis for Silence Therapeutics Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that sales are expected to reverse, with a forecast 15% annualised revenue decline to the end of 2024. That is a notable ch
Show less
Read more
Impact Snapshot
Event Time:
SLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLN alerts
High impacting Silence Therapeutics Plc - American Depository Share news events
Weekly update
A roundup of the hottest topics
SLN
News
- Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor ConferenceBusiness Wire
- Bitterroot Bio kickstarts Phase I trial for cardiovascular disease candidate [Yahoo! Finance]Yahoo! Finance
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors [Yahoo! Finance]Yahoo! Finance
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of DirectorsBusiness Wire
- Silence Therapeutics plc (NASDAQ: SLN) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $45.00 price target on the stock.MarketBeat
SLN
Sec Filings
- 5/1/24 - Form 6-K
- 4/29/24 - Form 6-K
- 4/15/24 - Form 6-K
- SLN's page on the SEC website